Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 91,009	$ 63,888
Accounts receivable, net	48,126	38,790
Inventory, net	17,774	11,312
Prepaid expenses and other current assets	2,099	3,769
Total current assets	159,008	117,759
Property and equipment, net	1,508	2,075
Goodwill	2,715	2,715
License and distribution rights, net	56,842	60,309
Other intangible assets, net	0	47
Total assets	220,073	182,905
Current liabilities:
Accounts payable and accrued liabilities	56,646	53,993
Total current liabilities	56,646	53,993
Notes payable, net	78,274	58,568
Other long-term liabilities	383	580
Total liabilities	135,303	113,141
Commitments and contingencies (Note 9)
Stockholders' equity:
Preferred Stock, 5,000,000 shares authorized; Series A Non-Voting Convertible Preferred Stock. $0.001 par value, 0 and 2,093,155 shares outstanding at June 30, 2020 and December 31, 2019, respectively; Series B Non-Voting Convertible Preferred Stock, $0.001 par value, 443 and 618 shares outstanding at June 30, 2020 and December 31, 2019, respectively.	0	2
Common Stock, $0.001 par value; 175,000,000 shares authorized at June 30, 2020 and December 31, 2019, respectively; 100,916,511 and 96,189,074 shares issued; 100,901,020 and 96,173,583 shares outstanding at June 30, 2020 and December 31, 2019, respectively.	99	96
Additional paid-in capital	445,180	436,306
Treasury stock, at cost,15,491 shares, as of June 30, 2020 and December 31, 2019.	(47)	(47)
Accumulated deficit	(360,462)	(366,593)
Total stockholders’ equity	84,770	69,764
Total liabilities and stockholders’ equity	$ 220,073	$ 182,905